

Portage, Michigan, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 2026 Jefferies Global Healthcare Conference on Tuesday, November 17, 2026, at the Waldorf Hilton and ME Hotel in London. Spencer Stiles, President, Chief Operating Officer, Preston Wells, Vice President, Chief Financial Officer and Nick Mead, Vice President, Investor Relations will also participate in a fireside chat session at 8:30 a.m.

Stryker Corporation remains a global leader in medical technologies, with strong segment breadth and robust product innovation. SYK delivered solid financial growth in H1 2026, with revenue up 6.1% and EBITDA rising to $3.45 billion. Management projects 2026 organic revenue growth of 8.3–9.3% and adjusted EPS of $14.95–$15.10, supported by demographic tailwinds.

Get a deeper insight into the potential performance of Stryker (SYK) for the quarter ended September 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

Portage, Michigan, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK), a global leader in medical technologies, announced it has completed the acquisition of ZuriMED, a privately held company and developer of the FiberLocker® System.


On October 22, 2026, Stryker Corp (SYK) shares rose 3.2%, reaching a current price of $307.08. This movement comes amid a 52-week range of $267.00 to $392.55, i

A dividend stock earns its place in a long-term portfolio by doing more than mailing shareholders a quarterly check. It needs a business that can fund those payments while investing sufficiently to stay “competitive.

Stryker (SYK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.